Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities

Abstract

Resveratrol (Res) is a well-known natural product that can exhibit important pharmacological activities such as antioxidant, anti-diabetes, anti-tumor, and anti-inflammatory. An evaluation of its therapeutic effects demonstrates that this naturally occurring bioactive compound can target different molecular pathways to exert its pharmacological actions. Transforming growth factor-beta (TGF-β) is an important molecular pathway that is capable of regulating different cellular mechanisms such as proliferation, migration, and angiogenesis. TGF-β has been reported to be involved in the development of disorders such as diabetes, cancer, inflammatory disorders, fibrosis, cardiovascular disorders, etc. In the present review, the relationship between Res and TGF-β has been investigated. It was noticed that Res can inhibit TGF-β to suppress the proliferation and migration of cancer cells. In addition, Res can improve fibrosis by reducing inflammation via promoting TGF-β down-regulation. Res has been reported to be also beneficial in the amelioration of diabetic complications via targeting the TGF-β signaling pathway. These topics are discussed in detail in this review to shed light on the protective effects of Res mediated via the modulation of TGF-β signaling.

Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects

“…Naturally occurring phytochemicals have numerous beneficial effects on human health [ 127 , 128 , 129 ]. They exhibit anticancer efficacy through the regulation of molecular cascades associated with cancer initiation, promotion and progression, including those for angiogenesis [ 130 , 131 , 132 , 133 ], hypoxia [ 134 ], metabolism [ 44 ], metastasis [ 135 ], apoptosis [ 136 , 137 ] and epigenetic machinery [ 138 , 139 , 140 ]. Zhang et al [ 141 ] evaluated the combined anticancer effects of melatonin and epigallocatechin-3 gallate (EGCG) in the HCC HepG2 cell line.…”

Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies

“…The resveratrol (Res) is a well-known compound in treatment of different ailments including diabetes, cancer and neurological disorders [ 340 , 341 ]. The recent years have witnessed an increase in attention towards Res application in cancer therapy.…”

Resveratrol as an anti-asthmatic agent: could this stilbenoid help against COVID-19 in any way? A meta-analysis

“…According to Dennis and Norris (2015), the proinflammatory cytokines and eicosanoids play a key role in the inflammatory process caused by SARS-CoV-2, in the same way as TNF-α, IL-6, IL-12, IL-17, IL-1β, and IFN- (Chousterman et al, 2017). Meanwhile, IL-10 limits the expansion of tissue lesions in experimental models (Savarin & Bergmann, 2018;Ashrafizadeh et al, 2020). Considering as described by Huang et al (2005), high levels of monokine were detected in the serum of patients with SARS in the acute phase, and these monokines are induced by IL-6, IL-8, IL-18, interferon-γ-inducible protein-10 (CXCL10 or IP-10), monocyte chemoattractant protein-1 (MCP-1), IFN-γ, and TGF-β (Huang et al, 2005;Savarin & Bergmann, 2018).…”